Forget the drug discovery hype. Here’s how the world’s largest pharma company is seeing a payoff from AI right now.
The split in outlook underscores Lilly's strong position in the obesity market, underpinned by more effective drugs and its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results